Little is known about the formation of niches, local micro-environments required for stem-cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem-cell (HSC) niche formation 1,2 . With this assay, we identified a population of progenitor cells with surface markers CD45 2 Tie2 2 a V 1 CD105 1 Thy1.1 2 (CD105 1 Thy1 2 ) that, when sorted from 15.5 days post-coitum fetal bones and transplanted under the adult mouse kidney capsule, could recruit host-derived blood vessels, produce donor-derived ectopic bones through a cartilage intermediate and generate a marrow cavity populated by host-derived long-term reconstituting HSC (LT-HSC). In contrast, CD45 2 Tie2 2 a V 1 CD105 1 Thy1 1 (CD105 1 Thy1 1 ) fetal bone progenitors form bone that does not contain a marrow cavity. Suppressing expression of factors involved in endochondral ossification, such as osterix and vascular endothelial growth factor (VEGF), inhibited niche generation. CD105 1 Thy1 2 progenitor populations derived from regions of the fetal mandible or calvaria that do not undergo endochondral ossification formed only bone without marrow in our assay. Collectively, our data implicate endochondral ossification, bone formation that proceeds through a cartilage intermediate, as a requirement for adult HSC niche formation.
Little is known about the formation of niches, local micro-environments required for stem-cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem-cell (HSC) niche formation 1, 2 . With this assay, we identified a population of progenitor cells with surface markers CD45 2 Tie2 2 a V 1 CD105 1 Thy1.1 2 (CD105 1 Thy1 2 ) that, when sorted from 15.5 days post-coitum fetal bones and transplanted under the adult mouse kidney capsule, could recruit host-derived blood vessels, produce donor-derived ectopic bones through a cartilage intermediate and generate a marrow cavity populated by host-derived long-term reconstituting HSC (LT-HSC). In contrast, CD45 2 Tie2 2 a V 1 CD105 1 Thy1 1 (CD105 1 Thy1 1 ) fetal bone progenitors form bone that does not contain a marrow cavity. Suppressing expression of factors involved in endochondral ossification, such as osterix and vascular endothelial growth factor (VEGF), inhibited niche generation. CD105 1 Thy1 2 progenitor populations derived from regions of the fetal mandible or calvaria that do not undergo endochondral ossification formed only bone without marrow in our assay. Collectively, our data implicate endochondral ossification, bone formation that proceeds through a cartilage intermediate, as a requirement for adult HSC niche formation.
Growth and renewal in many tissues are initiated by stem cells, supported by the niches in which they reside [1] [2] [3] . Although recent work has begun to describe functional interactions between stem cells and their niches, little is known about the formation of stem-cell niches. Identification of the cells and processes that can generate, sustain and influence the HSC niche and haematopoiesis are critical for our understanding of normal haematopoiesis; stem-cell homing, trafficking and differentiation; and haematopoietic pathology 4-12 . There is a need for modular systems in which the cellular and molecular components of a niche can be genetically modified and studied in vivo.
We have established an in vivo assay that allows functional assessment of the formation and maintenance of HSC niches at an ectopic site. We hypothesized that circulating HSC would colonize a nonhaematopoietic location and establish functional haematopoiesis if appropriate niche components were present. We selected the subcapsular site of the kidney because it possesses a rich vascular supply, supports several kinds of tissue engraftment and is not known to contain HSCs. In mice, HSCs are not detectable in the limb bone rudiment until 17.5 days post-coitum (d.p.c.) 13 . In our initial experiments, we showed that transplantation of 14.5 d.p.c. fetal bones under the kidney capsule, into either green fluorescent protein (GFP) transgenic or CD45 congenic hosts, resulted in the formation of donorderived bones with host-derived marrow and HSCs ( Supplementary  Fig. 2 ). This result indicates that 14.5 d.p.c. fetal bones contain elements that can initiate an ectopic niche. To determine if the fetal bones must be intact for niche initiation, we dissociated the 14.5 d.p.c. fetal bones into a single cell suspension, embedded the suspension in Matrigel, and introduced it under the kidney capsule. The suspension generated both cartilaginous and membranous bones that were populated with phenotypic and functional HSC ( Fig. 1a Supplementary Figs 1a, b and 5). To distinguish donor from host tissue, we transplanted either fetal bones from GFP transgenic mice or wild-type fetal bone suspension transduced with lentiviral-GFP. The haematopoietic and vascular components within the ectopic niche were host derived; non-haematopoietic and non-vascular components, including bone and cartilage, were donor derived ( Supplementary Figs 2-4) . The engraftment and activity of host HSC within these ectopic niches has been verified by surface marker phenotype and functional long-term engraftment assays in secondary recipients (Supplementary Figs 1a, b and 5). We did not detect HSCs either in the ungrafted kidneys of transplanted mice or in kidneys transplanted with Matrigel only ( Supplementary Fig. 1a, b ). To determine the kinetics of HSC colonization relative to ectopic bone formation, we evaluated both the presence of LT-HSC and histological parameters of bone formation at 8-day intervals over a period of 32 days. Donor-derived bone was present at day 16 post-transplant, coincident with the appearance of erythrocytes ( Fig. 1e ) and hostderived PECAM 1 vasculature ( Supplementary Figs 3 and 4 ). By day 24, c-kit 1 progenitors appeared; however, host-derived HSC were not detected until day 32. The day 32 grafts were structurally similar to normal bones with regions of cartilaginous, compact and trabecular bone ( Fig. 1b-e ). The presence of HSCs was found to be stable after the ectopic niche was established (data not shown). 
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To characterize the progenitors responsible for bone formation and their role in haematopoietic niche formation and maintenance further, we fractionated fetal-bone cell suspensions with a panel of cellsurface markers for: putative mesenchymal stem cells (CD105 and Thy1.1); the angiopoietin receptor that is on a variety of haematopoietic and vascular cells (Tie2) (ref. 8); haematolymphoid cells (CD45); and a vascular integrin (a V integrin) 14 . CD105 and Thy1.1 are also expressed on haematopoietic and endothelial cells, but these cell types were negatively gated from the skeletal progenitors with CD45 and Tie2, respectively. By transplanting distinct donor fractions sorted by flow cytometry, we identified the minimal progenitor population required for the formation of a functional ectopic HSC niche. We found that CD105 1 Thy1 2 progenitors consistently gave rise to bone with incorporated HSC-containing-marrow, whereas equal numbers of CD105 1 Thy1 1 progenitors resulted in bone formation without marrow (Fig. 2a-c and Supplementary Fig 1c) . CD105 2 Thy1 2 populations did not form bones or niches efficiently. Thus far, we have not observed marrow formation without bone, which suggests that bone forming cells such as osteoblasts, osteoblast progenitors and/or osteoblast-associated cells may be at least indirectly or structurally important for niche formation. It is important to note, however, that neither osteoblasts nor osteoblast progenitors alone were sufficient to initiate niche formation and HSC engraftment as the CD105 1 Thy1 1 population generated marrowless bone. To differentiate between the CD105 1 Thy1 2 bone niche-generating and the CD105 1 Thy1 1 bone-generating populations, we conducted timecourse studies to compare the respective mechanisms of bone formation. We transplanted equal numbers of each population and harvested the grafted kidneys at 16 and 32 days post-transplantation for histological characterization. We found that only CD105 1 Thy1 2 progenitors formed bones through a cartilage intermediate, also known as endochondral ossification, whereas CD105 1 Thy1 1 progenitors formed bones without a detectable cartilage intermediate (Fig. 2b, c) . Furthermore, we found that expression of osteocalcin, a marker of mature osteoblasts 15 , was fivefold higher in CD105 1 Thy1 1 populations derived from 15.5 d.p.c. fetal bones ( Supplementary Fig. 1d, e ). These results suggest that CD105 1 Thy1 1 progenitors may have lost chondrocyte potential 16 .
To assess the importance of specific candidate factors for niche development and HSC maintenance, we suppressed the expression of steel factor (SLF), osterix and VEGF. SLF is essential for adult haematopoiesis and HSC activity 17 , and is expressed both by mature osteoblasts 18 and endothelial cells 19 . We inhibited expression of SLF by transducing fetal bone suspensions with a GFP-labelled, SLFspecific short hairpin RNA (shRNA) lentiviral vector before renal capsule transplant (Fig. 3d ). We observed normal osteogenesis and niche formation when SLF expression was inhibited (Fig. 3a,  c) . HSC engraftment was similar between mock-transduced and SLF-deficient grafts, consistent with our previous observation that SLF production is not essential for haematopoiesis during the fetal period 20, 21 . To confirm the results of the knockdown, we transplanted intact 14.5 d.p.c. fetal bones from SLF null mutant (Sl/Sl) and again did not observe defects in either osteogenesis or niche formation (Fig. 3b, c) . This indicates that the SLF produced by skeletal progenitors and mature bone tissue is not required for initiation or maintenance of niche activity. We next silenced expression of osterix (Fig. 3e) , a transcription factor necessary for endochondral ossification, in fetal bone suspensions using lentivirus vector for osterixspecific shRNA 21, 22 . The osterix knockdown severely inhibited osteogenesis and abolished niche formation, underscoring the dependence of niche formation on the process of endochondral ossification. Because perichondrial cells and chondrocytes in the developing limb express high levels of VEGF, and vascular invasion is critical to endochondral ossification 23 , we tested whether VEGF activity was required for niche formation. We suppressed endogenous VEGF by injecting the host mice with adenovirus expressing soluble VEGF receptor (soluble Flk1; Ad-solVEGFR2), a known VEGF-inhibiting reagent 24 . We found that endochondral ossification was disrupted when 13.5 d.p.c. fetal bones were transplanted into hosts treated with Ad-solVEGFR2 but not into hosts treated with control virus (Ad-Fc). The 13.5 d.p.c. fetal bones grafted into Ad-solVEGFR2 mice displayed an accumulation of chondrocytes without perfusing vasculature and marrow cavity, although total HSC numbers in the host were not significantly affected (Fig. 3f ) 25 . To test further the hypothesis that niche formation requires endochondral ossification, we isolated CD105 1 Thy1 2 progenitors from the regions of fetal mandible and calvaria that form bone primarily through intramembranous ossification 26 , which occurs without a cartilaginous intermediate. In these experiments CD105 1 Thy1 2 mandibular and calvarial progenitors could only form marrowless bones, even 60 days after transplantation (Fig. 4) . These results suggest that endochondral ossification is necessary for niche formation.
A better functional understanding of the HSC niche was gained by observing how it is formed. In this study, CD105 1 Thy1 2 skeletal progenitors isolated from fetal limb bones initiated ectopic HSC niche formation. The progenitors gave rise to donor-derived chondrocytes, which recruited host-derived vasculature into the centre of the developing bone graft. As endochondral ossification proceeded, the recruited vasculature facilitated the filling of the niche with hostderived haematopoietic cells: first erythroid and myeloid, then c-kit 1 progenitors, and finally the HSCs. We do not yet know if the CD105 1 Thy1 2 cells represent a homogeneous population, or phenotypically similar but heterogeneous subsets. In agreement with our findings, Sacchetti et al. recently identified CD146 1 subendothelial cells residing in adult human bone marrow stroma that can generate both bone and marrow when transplanted under the skin of immunodeficient mice 27 . Although their study did not verify the presence of LT-HSC in the subdermal grafts, it is possible that osteoprogenitors in the adult marrow are involved in maintaining the niche. In addition to identifying the fetal-bone-derived skeletal progenitors that are capable of both endochondral ossification and HSC niche formation, our study provides a functional framework by which, in combination with previously described methods 6,7 , HSC-niche interactions can be further investigated at the cellular level.
METHODS SUMMARY
C57/BL6 CD45.1/2 congenic mouse strains were derived and maintained in our laboratory. Timed embryos from GFP transgenic HZ mice were used in most of the fetal bone transplantation studies. Sl/1 mice were purchased from the Jackson laboratory.
Skeletal progenitors were isolated from fetal bones (humerus, radius, tibia, femur, pelvis, mandible without the condyle, and the individual frontal and parietal bones by collagenase digestion). Next, they were stained with antibodies against CD45, Tie2, a V integrin, CD105 and Thy1.1 for fractionation by fluorescenceactivated cell sorting (FACS). Sorted and unsorted skeletal progenitors were then injected underneath the renal capsule of 8-to 12-week-old anaesthetized mice.
SLF and osterix-specific shRNA knockdown constructs, active lentiviral stock and non-silencing shRNA constructs were generated as previously described 28 ( Supplementary Table 1 ). Fetal bone cell suspensions were transduced for 48 h with specific shRNA vectors or control, sorted for GFP expression and transplanted as described.
To assess HSC engraftment in ectopic niches, grafted regions were dissected from kidney and crushed by mortar and pestle. Dissociated cells were stained with fluorochrome-conjugated antibodies against CD45, lineage (CD3, CD4, CD5, CD8, B220, Gr-1, Mac-1 and Ter119), c-kit, Sca-1 and CD150 for FACS analysis. Sorted KLS, CD150 1 LT-HSC were transplanted into lethally irradiated (800 rad delivered in split dose) 8-to 12-week-old congenic recipients by intravenous injection for functional analysis. Peripheral blood was obtained from the tail vein at 4 and 23 weeks after LT-HSC transplantation to assess donor-derived contributions by FACS.
Histological analyses of endochondral ossification were performed on sections that were obtained from either fresh frozen, optimal cutting temperature media (OCT)-embedded or formaldehyde-fixed, paraffin-embedded specimens. Representative sections were stained with either haematoxylin and eosin, Movat's modified pentachrome 29 , Safranin-O or Alizarin Red stains, depending on the experiments.
RNA was extracted from sorted cells using Trizol (Invitrogen) or RNeasy RNA isolation kits (Qiagen) and was reverse-transcribed into complementary DNA (cDNA) with SuperscriptRT III (Invitrogen). SYBR Green Universal Master Mix and a GeneAmp 7000 or 7500 fast sequence detection system (Applied Biosystems) were used for real-time PCR with the primers listed in Supplementary Table 2 . Relative expression was calculated for each gene by the comparative CT (2 2DDCT ) method with b-actin for normalization.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
